Japanese drugmaker Eisai and US-based Biogen have been working together on advancing research in the space of Alzheimer’s for nearly a decade. Finally, the FDA, granted the fruits of that labor, Leqembi, its blessing for intravenous use. This marks the first approved treatment that can slow the progression of Alzheimer’s.

  • @CaptainPicard
    link
    English
    81 year ago

    Currently doing that. It’s fucking brutal.

    • @VoxelBase
      link
      English
      21 year ago

      I’m so sorry to hear that, it fucking sucks. Cherish the moments that you have left.